State of HCV Care in the U.S. and Impact on the National Provider Workforce
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Reaching and engaging rural populations in care and treatment is critical to ending the HIV epidemic. Engaging the community and including faith institutions are key to improve access to care, treatment, and adherence. This session will highlight how three projects are working with implementing partners in the rural South.
Resource (Conference Presentation) updated 09/14/2023
As HIV elimination activities increase, jurisdictions can address HIV/Hepatitis C (HCV) co-infection by enhancing HCV screening and treatment data collection. This session will discuss NASTAD's work with North Carolina to incorporate HCV data in CAREWare and electronic health records (EHRs), as well as recommendations for integrating HCV services into the HIV care infrastructure.
Resource (Conference Presentation) updated 09/14/2023
This sub-study compared viral suppression between SPNS participants and non-participants at the Meharry site. The SPNS study enrolled women of color newly who were recently diagnosed with HIV or lost to care. There was no statistically significant difference in viral suppression after controlling for demographic and clinical factors.
Resource (Conference Presentation) updated 09/14/2023
The Linkage to Care (LTC) Program at Denver Health/Denver Public Health is an innovative model using continuous quality improvement and community partners to close gaps in the HIV care continuum. This linkage model serves those seeking HIV prevention service as well as people with HIV seeking linkage and retention in care.
Resource (Conference Presentation) updated 09/14/2023
This session will discuss engagement and re-engagement of newly diagnosed clients and clients lost to care through the provision of personalized assistance and support designed to increase access to specialty care.
Resource (Conference Presentation) updated 09/14/2023
Learn how to develop, plan, and implement an organization-wide ECHO model to fully integrate HIV/HCV care and treatment into primary care centers and create wider access for patients with less barriers to care.
Resource (Conference Presentation) updated 09/14/2023
Among people with HIV who also inject drugs, an estimated 80 to 90 percent are coinfected with Hepatitis C (HCV.) This panel will provide updates on screening and referral activities and demonstrate how community and city partners are overcoming barriers to HCV care among PWID.
Resource (Conference Presentation) updated 09/14/2023
This session will discuss the implementation, outcomes, and future directions associated with the Health Services Center, Inc. Behavioral Health Co-location (BHC) Project. HSC is the sole provider of free HIV and Hepatitis C (HCV) services to a population facing multiple barriers to care (e.g., poverty, education and stigma) in a largely rural 14-county area of northeast Alabama.
Resource (Conference Presentation) updated 09/14/2023
Boston Healthcare for the Homeless Program will share its innovative approach toward the micro-elimination of Hepatitis C (HCV) for homeless-experienced people with HIV. Team members will share data around cure rates, reinfection, and engaging with marginalized patients, and discuss leveraging existing Ryan White infrastructure and resources for such efforts.
Resource (Conference Presentation) updated 09/14/2023
Panelists will describe collaborative prevention and support services provided to people with HIV and/or hepatitis from incarceration to re-entry. Services addressing social determinants of health are provided in corrections facilities and upon release. Panelists include the program director, staff from a correctional medical facility, and community-based organizations working inside and outside of correction facilities.
Resource (Conference Presentation) updated 09/14/2023
Improving access to HIV care is a critical component of engagement into and retention in care. This session will utilize patient-centered care principles to define healthcare access and its measures, and how a practice can measure demand for, and expand access to, HIV care and services.
Resource (Conference Presentation) updated 09/14/2023
This session will use a 'lightning round' series of brief presentations to share HAB-vetted and evidence-informed interventions, focusing on free tools and services available to help agencies adapt and adopt them in their own settings.
Resource (Conference Presentation) updated 09/14/2023
Ending the HIV Epidemic: A Plan for America provides an incredible opportunity for jurisdictions to assess their health systems, prevention activities, and linkage to care programs. It is important that health departments create innovative programs and examine how this initiative can be used to address viral hepatitis as well.
Resource (Conference Presentation) updated 09/14/2023
Explore how to leverage data visualizations created in Tableau in order to increase clinician access to HIV quality data and thereby motivating provider teams to improve quality measures. The session will also discuss an antiretroviral treatment (ART) dashboard created in Tableau.
Resource (Conference Presentation) updated 09/14/2023
This session will feature an interactive demo and feedback session of HRSA HAB's data dashboards and benchmarking project. Presenters will orient attendees to the project timeline and status. Throughout the session attendees will be able to provide feedback on product design including the presentation of data and benchmarking results.
Resource (Conference Presentation) updated 09/14/2023
The New York City Health Department data-to-care model to eliminate Hepatitis C in people with HIV uses surveillance data to target health care practices for training and clinical practice facilitation, to identify patients for outreach and linkage to care, and to monitor progress toward elimination.
Resource (Conference Presentation) updated 09/14/2023
The HCV Consultation Line (HEPline) has received multiple cases involving Hepatitis C (HCV) treatment interruptions with prescribers asking for guidance on best approaches. This presentation reviews representative HCV cases where treatment interruptions provide lessons in improving systems of care to prevent treatment lapses and optimize the chance of HCV cure.
Resource (Conference Presentation) updated 09/14/2023
Resource from the RWHAP Best Practices Compilation updated on 01/17/2024